Category: your-feed-healthcare

Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.

Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.

After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.

After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.

After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.

After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.

El desarrollo de las vacunas superó las expectativas de todos. Pero durante los próximos meses muchas personas enfermarán y, lamentablemente, los médicos tienen pocos fármacos para tratarlas.

El desarrollo de las vacunas superó las expectativas de todos. Pero durante los próximos meses muchas personas enfermarán y, lamentablemente, los médicos tienen pocos fármacos para tratarlas.

Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.

Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.

Infectious disease doctors say getting a shot of the J&J vaccine, which has a lower efficacy against the virus than other vaccines, would still be well worthwhile.

The W.H.O. and the C.D.C. provide differing views, and experts partly blame a lack of data because expectant mothers have been excluded from clinical trials.

After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.

After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.

Can President Biden really boost production? Why are governors trying to buy directly from Pfizer? And when will supply exceed demand?

But with 200 million doses pledged for the first quarter of the year, some experts say President Biden’s plan for 100 million shots in 100 days is far too modest.

But with 200 million doses pledged for the first quarter of the year, some experts say President Biden’s plan for 100 million shots in 100 days is far too modest.

Can President Biden really boost production? Why are governors trying to buy directly from Pfizer? And when will supply exceed demand?

Can President Biden really boost production? Why are governors trying to buy directly from Pfizer? And when will supply exceed demand?

The big dip in mortality shown in the trial of about 800 patients has caught some experts by surprise because previous studies of the drugs showed little benefit.

The big dip in mortality shown in the trial of about 800 patients has caught some experts by surprise because previous studies of the drugs showed little benefit.

The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.

Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.

Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.

Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.

The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.

While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.

While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.

While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.

Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.

Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.

The Food and Drug Administration authorized a second coronavirus vaccine for emergency use, clearing the way for millions more Americans to be immunized next week.

Four people so far have had allergic reactions after getting the Pfizer-BioNTech vaccine. Experts say that shouldn’t deter most people from getting a jab.

The smaller number of expected doses, which appeared to be the result of a scheduling hiccup, reignited tensions between the federal government and Pfizer over vaccine supply.

The smaller number of expected doses, which appeared to be the result of a scheduling hiccup, reignited tensions between the federal government and Pfizer over vaccine supply.

The smaller number of expected doses, which appeared to be the result of a scheduling hiccup, reignited tensions between the federal government and Pfizer over vaccine supply.

An advisory group’s recommendation will mean millions more Americans can be inoculated, extending protection against Covid beyond big urban areas into rural and suburban regions.

La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.

La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.

La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.

The positive review likely ensures that the F.D.A. will approve a second coronavirus vaccine this week for millions of Americans.

Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.

Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.

Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.

British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.

The company said the trial would involve children ages 12 through 17.

The three-month pilot program involves just 1,000 doses of the medication in seven big cities. It’s not clear how much impact that will have as demand surges.

The first shots could be given as early as Dec. 21, if authorization is granted.

A large team of regulators at the agency will take about three weeks to review an application spanning thousands of pages.

The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.